Recent progress in the tumor necrosis factor-α field

International Archives of Allergy and Immunology

Volumn 111, Issue 3, 1996, Pages 199-209

  Rink, Lothar ^a   Kirchner, Holger ^a  

^a University of Lübeck School of Medicine   (Japan)

Author keywords

Autoimmunity; Gene polymorphism; Infectious diseases; Transplantation; Tumor necrosis factor receptor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

AUTOIMMUNITY; DNA POLYMORPHISM; GENE STRUCTURE; GENETIC TRANSCRIPTION; INFECTION; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; ENDOTHELIUM; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; ORGAN TRANSPLANTATION; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029856502     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237369     Document Type: Article

References (120)

1. Nicola NA: Guidebook to Cytokines and Their Receptors. Oxford. Oxford University Press. 1994.
2. Hamblin AS: Cytokines and Cytokine Receptors. Oxford. IRL Press. 1993.
3. Fong CLW., Siddiqui AH, Mark OF: Characterization of protein complexes formed on the repressor elements of the human tumor necrosis factor alpha gene. J Interferon Cytokine Res 1995:15:887-895.
4. Trede NS, Tsytsykova AV., Chatila T., Goldfeld AE., Geha RS: Transcriptional activation of the human TNF-alpha promoter by supcrantigcn in human monocytic cells - Role of NF-kappa-B. J Immunol 1995:155:902-908.
5. MccalTrey PG., Goldfeld AE., Rao A: The role of NFATP in cyclosporin A-scnsitive tumor necrosis factor-alphy gene transcription. J Biol Chem 1994:269:30445-30450.
6. Krämer B., Wiegmann K., Kronke M: Regulation of the human TNF promoter by the transcription factors ets. J Biol Chem 1995:270: 6577-6583.
7. Rhoades KL., Cai SJ., Golub SH., Economou JS: Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate the human tumor necrosis factor-alpha promoter region. Cell Immunol 1995:161:125-131.
8. Krämer B, Machleidt T., Wicgmann K., Kronke M: Superantigen-induccd transcriptional activation of the human TNF gene promoter in T cells. J Inflamm 1995;45:183-192.
9. Rink L., Nicklas W., Alvarez-Ossorio L., Koester M., Kirchner H: TNF-a-induction by Mycoplasma aiilirllides-dcrived supcrantigcn (MAS) is MHC II haplotype-specific. EurCytokineNetvv 1994:5:173.
10. Kruys V., Kemmer K, Shakhov A, Jongeneel V., Beutler B: Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in non-macrophage cell lines: A trans-dominant factor overcomes this suppressive effect. Proc Natl Acad Sei USA 1992; 89:673-677.
11. Kruvs V., Abdelaziz S., Huef G: Identification of protein binding TNF niRNA UA-rich sequence, disruption of the interaction correlated with TNF synthesis. Eur Cytokine Netvv 1994:5:144.
12. Biragyn A., Nedospasov SA: Lipopolysaccha-ride-induccd expression of TNF-alpha gene in the macrophage cell line ANA-1 regulated at the levels of transcription processivity. J Immunol 1995:155:674- 683.
13. Prichett W., Hand A., Sheilds J., Dunnington D: Mechanism of action bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor alpha. J Inflamm 1995:45: 97-105.
14. Rink L., Nicklas W., Alvarez-Ossorio L., Koester M., Kirchncr H: Differential induction of tumor necrosis factor alpha in murine and human leukocytes by mycoplasma art/tnVi«fex-derived superantigen. Infect lmmun 1994:2:462-467.
15. Al-Daccak R., Mehindatc K., Hebert J., Rink L, Mecheri S, Mourad W: Mycoplasma arthri-tides-derived superantigcn induces proinfiam-matory monokine gene expression in TUP-1 human monocytic cell line. Infect lmmun 1994; 6:2409-2416.
16. Mehindatc K., Al-Daccak R., Rink L., Hebert J., Mourad W: Regulation of MAM-induced proinflammatory monokine gene expression by dcxamethasone and IL-4. Infect lmmun 1994; 11:4716-4721.
17. Eigler A., Moeller J., Endres S: Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J Immunol 1995; 154:4048-4054.
18. Altavilla D., Squadrito F., Canale P., loculano M., Squadrito G., Campo GM., Serrano M., Sardclla A., Urna G., Spignoli G, Caputi AP: G 619. a dual thromboxane synthase inhibitor and thromboxane A (2) receptor antagonist, inhibits tumour necrosis factor-alpha biosynthesis. Eur J Pharmacol 1995;286:31-39.
19. Wilson AG., di Giovinc FS, Duff GW: Genetics of tumor necrosis factor-ct in autoimmune, infectious. and neoplastic diseases. J Inflamm 1995:48:1-12.
20. Mizuki N., Ohno S., Sato T., Ishihara S., Miyata S., Nakamura S, Naruse T., Mizuki II. Tsuji K., In-oko H: Microsatellite polymorphism between the tumor necrosis lactor and IILA-B genes in Behcet's disease. Hum Immunol 1995:43:129-135.
21. Hamann A., Mantzoros C, Vidalpuig A., Flier JS: Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995:211:833-839.
22. Brinkman BMN., Kaijzel F.L., Huizinga TWJ, Giphart MJ., Breedvcld FC., Verweij CL: Detection of a C'-inscrtion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 1995:96:493.
23. Utsumi T., Akimaru K., Kavvabata Z., Levitan A., Tokunaga T., Tang P., Ide A., Hung MC., Kloster-gaard J: Human pro-tumor necrose factor Molecular determinants of membrane translocation. sorting, and maturation. Mol Cell Biol 1995:15:6398-6405.
24. Gearing AJH., Beckett P., C'hristodoulou M., Churchill M., Clements JM., Crimmin M., Davidson AH., Drummond AH, Galloway WA, Gilben R., Gordon JL., Leber TM., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G, Wood LM, Woolley K: Matric metal-loproteinases and processing ofpro-TNF-alpha. J Leukoc Biol 1995:57:774-777.
25. Crowe PD, Walter BN, Mohler KM., Ottcncvans C., Black RA., W'arc CF: A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J ExpMcd 1995:181:1205-1210.
26. Grell M., Douni E., Wajant H, Lohden M., Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G., Pfizcnmaier K., Schcurich P: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 1995:83:793-802.
27. Dccoster E., Vanhaesebroeck B., Vandenabecle P., Grooten J., Fiers W: Generation and biological characterization of membrane-bound, unclcav-able murine tumor necrosis factor. J Biol Chem 1995:270:18473-18478.
28. Robachegallca S., Morand V., Bruneau IM, Sehoot B., Tagat E., Realo E., Chouaib S, Roman-roman S: In vitro processing of human tumor necrosis factor-alpha. J Biol hem 1995:270: 23688-23692.
29. Illodan R., Pain RH: The folding and assembly pathway of tumor necrosis factor TNF-alpha, a globular trimeric protein. Eur J Biochem 1995: 231:381-387.
30. Guo DL, Shen BH, Dong XY, Qiu QF, Xu XX: Creation of a high cytotoxic active human tumor necrosis factor having the truncated and more basic amino terminus. Biochem Biophys Res Commun 1995:207:927-932.
31. Mcguinncss MC, Griffin DF., Raymond GN, Washington CA, Moser HW, Smith KD: Tumor necrosis factor-alpha and X-linked adrenoleu-kodystrophy. J Neuroimmunol 1995:61:161-169.
32. Vandenabcele P, Declercq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 1995:5:392-399.
33. Warzocha K, Bienvenu J., Coiffier B, Salles G: Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Eur Cytokine Netw 1994:5:83-96.
34. Diez-Ruiz A., Tilz GP, Zangcrlc R., Baier-Bitter-lieh G., Wächter H., Fuchs D: Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995;54:1-8.
35. Naismith JH., Devine TQ, Brandhuber BJ., Sprang SR: Crystallographic evidence for di-merization of unliganded tumor necrosis factor receptor. J Biol Chem 1995:270:13303-13307.
36. Bazzoni F., Alejos E., Beutler B: Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc Natl Acad Sei 1995:92: 5376-5380.
37. Boldin MP., Mctt IE., Wallach D: A protein related to a proteasomal subunit binds to the intracellular domain of the P55 TNF receptor upstream to its death domain. FEBS Lett 1995; 367:39 44.
38. Leist M, Gantner F., Jilg S., Wendel A: Activation of the 55 kDa TNF receptor is necessary and sufficient I'orTNF-induced liver failure, he-patocyte apoptosis. and nitrite release. J Immunol 1995:154:1307-1316.
39. Takahashi N., Brouckaert P., Fiers W: Mechanism of tolerance to tumor necrosis factor - receptor-specific pathway and selectivity. Am.1 Physiol 1995;38:R398-R405.
40. Vandenabcele P., Declercq W., Vanhaesebrock B., Grooten J, Fiers W: Both TNF receptors are required for TNF-mcdiated induction of apoptosis in PC60 cells. J Immunol 1995; 154:2904-2913.
41. Schmid F.F., Binder K., Grell M., Scheurieh P., Pfi-zenmaicr K: Both tumor necorsis factor receptors. TNFR6Ö and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrinc tumor necrosis factor alpha. Blood 1995;86:1836-1841.
42. Sarin A., Conancibotti M., Henkart PA: Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J Immunol 1995:155:3716-3718.
43. Medvedev AE., Sundan A., Espevik T: Involvement of the tumor necrosis factor receptor P75 in mediating cytotoxicity and gene regulating activities. Eur J Immunol 1994:24:2842-2849.
44. Murphy M., Pikenobile L., Soo VW., Epstein LB: Characterization of TNF receptors on human thymocytes. Thymus 1994:23:177-194.
45. Brakebusch C., Varfolomeev EE., Batkin M., Wallach D: Structural requirements for inducible shedding of the P55 tumor necrosis factor receptor. J Biol Chem 1994;269:32488-32496.
46. Björnberg F., Lantz M, Gullberg U: Mctallopro-teases and serine proteases are involved in the cleavage of the two tumour necrosis factor (TNF) receptors to soluble forms in the myeloid cell lines U-937 and THP-1. Scatid J Immunol 1995:42:418-424.
47. Tilg H., Vogel W., Dinarello CA: Intcrferon-alpha induces circulating tumor necrosis factor receptor P55 in humans. Blood 1995:85:433-435.
48. Arend AP, Daycr JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor u in rheumatoid arthritis. Arthritis Rheum 1995:2:151-160.
49. Cope AP., Maini RN: Soluble tumor necrosis factor receptors in arthritis. J Rheumatol 1995; 22:382-384.
50. Sakito S., Ucki Y., Eguchi K., Kawabe Y, Nagata-ki S: Serum cytokines in patients with rheumatoid arthritis - Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells. Rheumatol Int 1995:15:31-37.
51. Narin N, Kutukculcr N, Ozyurck R, Bakiler AR, Parlar A, Arcasoy M: Lymphocyte subsets and plasma 1L-1-alpha. IL-2. and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Clin Immunol Immunopathol 1995:77:172-176.
52. Rink A, Alvarez-Ossorio L, Johannsen M, Nicklas W, Kiestcr M, Kirchner II: Mycoplasma artlirilUles-derived superantigen induces TNF-ct in a HLA-DR-haplotype-specific manner inT cells. Immunobiology 1995:194:321.
53. Brennan FM, Gibbons DL, Cope AP, Katsikis P, Maiani RN, Feldntann M: TNF inhibitors are produced spontaneously by rheumatoid and os-teoarthritic synovial joint cell cultures Evidence of feedback control of TNF action. Scand.1 Immunol 1995;42:158-165.
54. Maini RN, Elliott MJ, Charles PJ, Feldmann M: Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus. Semin Immunopathol 1994; 16:327 -336.
55. Inagaki Y, Truter S, Tanaka S, Diliberto M, Ramirez F: Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha-211 collagen gene transcription. J Biol Chem 1995:270:3353-3358.
56. Chidwick K, Whichelow CE, Zhang Z, Fairbum K, Sachs JA, Blake DR, Winyard PG: Relationship between alpha I J-antitrypsin inactivation and tumor necrosis factor alpha concentration in the synovial fluid of patients with rhcumatiod arthritis. Arthritis Rheum 1994;37:1723-1726.
57. Roubenoff R, Roubcnoff RA, Selhub J, Nadeau MR, Cannon JG, Freeman LM, Dinarello CA, Rosenberg IH: Abnormal vitamin B-6 status in rheumatoid cachexia Association with spontaneous tumor necrosis factor alphy production and markers of inflammation. Arthritis Rheum 1995:38:105-109.
58. Elliott MJ, Feldmann M, Maini RN: TNF-alpha blockade in rheumatoid arthritis Rationale, clinical outcomes and mechanisms of action. Int J Immunopharmacol 1995:17:141-145.
59. Alvarez-Ossorio L, Johannsen M, Russlies M, Kirchner II, Rink L: Heterogenous immune to Mycoplasma arlhritides-ticrived superantigen in patients' rheumatic diseases. Cytokine 1995: 7:626.
60. Yang XD, Mcdevitt HO: Role of TNF-alpha in the development of autoimmunity and the pathogenesis of insulin-dependent diabetes mellitus in nod mice. Circ Shock 1994:43:198-201.
61. Norman JG, Fink GW, Franz MG: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995:130: 966-970.
62. Pociot F, Mövig J, Wogcnscn L, Worsaae H, Dalböe H, Back L, Nerup J: A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991:33:37-49.
63. Pociot F, Briant L, Jongenecl DV, Mölvig J, Worsaae FI, Abbal M, Thomsen M, Nerup J, Thomasen AC: Assocition of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-ct and TNF-ß by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993:23:224-231.
64. Monos DS, Kamoun M, Udalova I A, Csanky E, Cizman B, Turetskaya RL, Smirnova IB, Zhar-kov VG, Gasser D, Zmijcwski DM, Spielman RS, Nedospasov SA: Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus Linkage disequilibrium ofTNFab microsatellite alleles with HLA haplotvpes. Hum Immunol 1995:44: 70-79.
65. Malidc D, Russo P, Bendayan M: Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 1995:26:558-564.
66. van der Poll T, Lowry SF: Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 1995:3:1 12.
67. Cavaillon JM: Controversies surrounding current therapies for sepsis syndrome. Bull Inst Pasteur 1995:93:21-41.
68. Ertel W, Scholl FA, Gallati H, Bonacccio M, Schildberg FW, Trentz O: Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch Surg 1994: 129:1330-1337.
69. Schroder J, Stubcr F, Gallati Fl, Schade FU, Klemer B: Pattern of soluble TNF receptors I and 11 in sepsis. Infection 1995:23:143-148.
70. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality. but not the lethality of cecal ligation and puncture. Shock 1995;4:89-95.
71. Barthlen W, Stadler J, Lehn NL, Miethke T, Bartels H, Sicwert JR: Scrum levels of end products of nitric oxide synthesis correlate positively with tumor necrosis factor a and negatively with body temperature in patients with postoperative abdominal sepsis. Shock 1994:2: 398-401.
72. Mandi Y, Farkas G, Ocsovszky I, Nagy Z: Inhibition of tumor necrosis factor production and ICAM-I expression by pentoxifylline - Beneficial effects in sepsis syndrome. Res Exp Med 1995:195:297-307.
73. Cosentino G, Soprana E, Thienes CP, Siccardi AG, Vialc G, Vcrcelli D: 1L-I3 down-regulatcs CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol 1995: 155:3145-3151.
74. Casas AT, Hübsch AP, Rogers BC, Doran JE: Reconstituted high-density lipoprotein reduces LPS-stimulated TNF-alpha. J Surg Res 1995: 59:544-552.
75. Pallares-Trujillo J, Lopez-Soriano FJ, Argiles JM: TNF and AIDS: Two sides of the same coin? Med Res Rev 1995:6:533-546.
76. Kaplan G, Moreira AL: TNF-alpha regulation of HIV I Biology and therapy. Res Immunol 1994:145:685-689.
77. Dezube BJ, Ledcrman MM, Spritzlcr JG, Chapman B, Korvick JA, Flexner C, Dando S, Mat-tiacci MR, Ahlers CM, Zhang L, Novick WJ, Kasdan P, Fahey JL, Pardee AB, Crumpacker CS: High-dosc pentoxifylline in patients with aids Inhibition of tumor necrosis factor production. J Infect Dis 1995:171:1628-1632.
78. Navikas V, Link J, Persson C, Olsson T, Hoje-bcrg B, Ljungdahl A, Link H, Wahren B: Increased m RN A expression of IL-6,1L-10. TN F-alpha, and perforin in blood mononuclear cells in human HIV infection. J Acquir Immune Def-ic Syndr 1995:9:484-489.
79. Kalinkovich A, Geleziunas R, Kemper O, Belenki D, Wallach D, Wainberg MA, Bentwich Z: Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type I infection. J Interferon Cytokine Res 1995:15:749-757.
80. Tracey KI: TNF and West, Mac or death from too much of a good thing. Lancet 1995:345:75-76.
81. Clark I A, Rockett KA: TNF. malaria, and sepsis. Lancet 1995:345:929.
82. Kwiatkowski D, Bate C: Inhibition of tumour necrosis factor (TNF) production by antimalar-ial drugs used in cerebral malaria. Trans R Soc Trop Med Hyg 1995:89:215-216.
83. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK: Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoprolifcra-tion in acute Ptasmoilium falciparum malaria. J Infect Dis 1995:172:838-844.
84. Garcia I, Miyazaki Y, Araki K, Araki M, Lucas R, Grau GE, Milon G, Belkaid Y, Montixi C, Lesslauer W, Vassalli P: Transgenic mice expressing high levels of soluble TNF-RI fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to listeria monocytogenes and Leishmania major infections. Eur J Immunol 1995:25:2401-2407.
85. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatowski D: Variation in the TNF-tt promoter region associated with susceptibility to cerebral malaria. Lancet 1992:340: 894-896.
86. Allan RJ, Beattie P, Bate G, Vanhcnsbroek MB, Morrisjones S, Greenwood BM, Kwiatowski D: Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria. Infect Immun 1995:63:1173-1175.
87. Cabrera M, Shaw M A, Sharpies C, Williams H, Castes M, Convit I, Blackwell JM: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995:182:1259-1264.
88. Okomoassoumou MC, Dauloucdc S, Lemesre JL, Nzilamouanda A, Vincendcau P: Correlation of high scrum levels of tumor necrosis fac-tor-alpha with disease severity in human African trypanosomiasis. Am.1 Trop Med Hyg 1995:53:539-543.
89. Silva IS, Vespa GNR, Cardoso MAG, Aliberti JCS, Cunha FQ: Tumor necrosis factor alpha mediates resistance to Trypanosoma crttzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995:63:4862-4867.
90. Rivera MT, Dearaujo SM, Lucas R, Dcman J, Truyens C, Defresne MP, Debaetselier P, Carlier Y: High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma crttzi infected pregnant mice and increased TNF-alpha gene transcripition in their offspring. Infect Immun 1995:63:591-595.
91. Danzer S, Kirchner H, Rink L: Cytokine interactions in human mixed lymphocyte culture. Transplantation 1994:11:1638-1642.
92. Danzer S, Campo C, Kunze B, Kirchner H, Rink L: Identification of HLA-DRBI and HLA-DQB1 identical individuals by a cyto-kine-based mixed lymphocyte culture. Lym-phokine Cytokine Res 1994:13:303-308.
93. Toungouz M, Denys CH, Andrien ME, De-groote D, Dupont EC: Tumor necrosis factor-a and interleukin-6 production induced by variations of DR4 polymorphism during the primary mixed lymphocyte reaction. Transplantation 1994:58:1393-1398.
94. Toungouz M, Denys C, Andrien M, Dupont E: HI.A DR subtypes induce IL-6 and TNF-alpha production in the primary mixed lymphocyte reaction. Transplant Proc 1995:27:461-462.
95. Danzer S, Rink L: Cytokines in mixed lymphocyte culture as prospective parameters for transplantation medicine. Med Klin, in press.
96. Danzer S, Rink L: Reverse transcription polymerase chain reaction (RT-PCR) for cytokines in the mixed lymphocyte culture (MIX) Is there a role in renal transplantation? Nephrol Dial Transplant, in press.
97. Rcmbcrgcr M, Ringdcn O, Markling L: TNF-alpha levels arc increased during bone marrow transplant conditioning in patients who develop acute GVHD. Bone Marrow Transplant 1995: 15:99-104.
98. Hagglund H, Boslrom L, Remberger M, Ljung-man P, Nilsson B, Ringdcn O: Risk factors for acute graft-vcrsus-host disease in 291 consecutive 11 LA-identical bone marrow transplant recipients. Bone Marrow Transplant 1995:16: 747-753.
99. Turner DM, Grant SCD, Lamb WR, Brenchley PEC, Dyer PA, Sinnot PJ, Hutchinson IV: A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 1995:60:1113-1117.
100. Dorgc SE, Rouxlombard P, Daycr JM, Koch KM, Frei U, Lonnemann G: Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 1994:58:1000-1008.
101. Wee S, Boskovic S, Eason JD, Widmer MB, C'osmi AB: Preclinica! study of a recombinant soluble tumor necrosis factor receptor Effect on immune response of renal allograft recipients. Transplant Proc 1995:27:411-412.
102. Lin H, Wei RQ, Bolling SF: Tumor necrosis factor-alpha and interfcron-gamma modulation of nitric oxide and allograft survival. J Surg Res 1995;59:103-110.
103. Jasinski M, Wieckiewicz J, Ruggiero I, Pituch-noworolska A, Zambala M: Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor. J Clin Immunol 1995:15:185-193.
104. Tanaka H, Swanson S.I., Sukhova G, Schoeti FJ, Libby P: Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 1995:147:617-626.
105. Rocssler K, Suchanek G, Breitschopf H., Kitz K., Malula C, Lassmann H, Koos WT: Detection of tumor necrosis factor-ex protein and messenger RNA in human glial brain tumors Comparison of immunohistochcmistry with in situ hybridization using molecular probes. J Ncurosurg 1995:83:291-297.
106. Garcia FU, Chen IIL., Yang Y, Pace JL, Hu XL., Hunt JS: Tumor necrosis factor-alpha mRNA and protein in endometrial tumors Analysis by in situ hybridization and immunocytoche-mislry. Hum Pathol 1994:25:1324-1331.
107. Lcjeune F, Lienard D, Eggermont A., Koops IIS, Kroon B, Gerain J, Rosenkaimcr F, Schmitz P: Clinical experience with high-dosc tumor necrosis factor alpha in regional therapy of advanced melanoma. Cue Shock 1994:43: 191-197.
108. Yang R, Lin Q, Rescorla FJ, Grosfeld JL: Experimental liver cancer Improved response after hepatic artery ligation and infusion of tumor necrosis factor-alpha and interfcron-gam-ma. Surgery 1995; 118:768-774.
109. Fraker DL, Alexander HR, Thom AK: Use of tumor necrosis factor in isolated hepatic perfusion. Circ Shock 1994;44:45-50.
110. I 10 Koga S. Morris S. Ogawa S. Liao H, Bilezikian IP., Chen G, Thompson WJ., Ashikaga T., Brett J., Stern DM., Pinsky DJ: TNF modulates endothelial properties by decreasing camp. Am J Physiol 1995:37:C1104-C1113.
111. Glazier DB., Balmson RR., Mcleod DG., Von-roemeling RW, Messing EM., Emstoff MS: Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer -An eastern cooperative oncology group study. J Urol 1995:154:66-68.
112. Crawford ED: Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer - An eastern cooperative oncology group study - Comment. J Urol 1995:154: 68.
113. Orosz P., Kruger A., Hubbe M., Ruschoff J, Von-hoegen P., Mannel DN: Promotion of experimental liver metastasis by tumor necrosis factor. Int J Cancer 1995:60:867-871.
114. Hagihara M, Shimura T., Sato K., Genga K., Suzuki M., Tsuji K: HLA and tumor necrosis factor beta gene polymorphisms in Okinawa lung cancer patients, comparative study with mainland Japan lung cancer patients. Hum Immunol 1995:43:95-100.
115. Shah A., Church MK., Ilolgate ST: Tumor necrosis factor alpha: A potential mediator of asthma. Clin Exp Allergy 1995:25:1038-1044.
116. Tabibzadch S, Kong QF., Kapur S., Leffcrs H., Ridley A., Aktories K., Celis JE: TNF-alpha induces dyscohesion of epithelial cells Association with disassembly of aetin filaments. En-docrJ 1995:3:549-556.
117. I'oborek M., Barger SW., Mattson MP., Mclain CJ, Hentiig B: Role of glutathione redox cycle in TNF-alpha-mediated endothelial cell dysfunction. Atherosclerosis 1995:117:179-188.
118. Stewart AG., Tomlinson PR., Fernandes DJ., Wilson JW., Harris T: Tumor necrosis factor alpha modulates mitogenic responses of human cultured airway smooth muscle. Am J Respir Cell Mol Biol 1995:12:110-119.
119. Bachurski CJ., Pryhubcr GS., GIasser SW., Kelly SE, Whitsett JA: Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J Biol Chem 1995:270:19402-19407.
120. Peper RL., Vancampen H: Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 1995:19: 175-183.